Exploration of the association between HIF3&alpha; mRNA and lncRNA MALAT1 in laryngeal squamous cell carcinoma by correlation analysis

Kyurkchiyan,Silva Garo; Stancheva,Gergana; Petkova,Veronika; Hadzhiev,Yuliyan; Dobriyanova,Venera; Popova,Diana; Kaneva,Radka; Popov,Todor Miroslavov

doi:10.3892/ol.2024.14425

Exploration of the association between HIF3α mRNA and lncRNA MALAT1 in laryngeal squamous cell carcinoma by correlation analysis

Authors:
- Silva Garo Kyurkchiyan
- Gergana Stancheva
- Veronika Petkova
- Yuliyan Hadzhiev
- Venera Dobriyanova
- Diana Popova
- Radka Kaneva
- Todor Miroslavov Popov
View Affiliations

Affiliations: Molecular Medicine Center, Department of Medical Chemistry and Biochemistry, Medical Faculty, Medical University, 1431 Sofia, Bulgaria, Department of Ear and Nose Treatment, UMHAT ‘Tsaritsa Yoanna‑ISUL’, Medical University, 1537 Sofia, Bulgaria
Published online on: May 1, 2024 https://doi.org/10.3892/ol.2024.14425
Article Number: 292
Copyright: © Kyurkchiyan et al. This is an open access article distributed under the terms of Creative Commons Attribution License.

Metrics: Total Views: 0 (Spandidos Publications: | PMC Statistics: )

Metrics: Total PDF Downloads: 0 (Spandidos Publications: | PMC Statistics: )

Cited By (CrossRef): 0 citations Loading Articles...

Abstract

Laryngeal squamous cell carcinoma (LSCC) is a significant global health burden, for which there has been limited evidence of improved survival rates. Although the roles of hypoxia‑inducible factor (HIF)1α and HIF2α have been well documented in hypoxia, the involvement of HIF3α, particularly in LSCC, has been inadequately explored. The present study aimed to investigate the correlation between HIFα subunits and the hypoxia‑related long noncoding RNAs (lncRNAs) MALAT1 and HOTAIR in 63 patients diagnosed with LSCC. Total RNA was extracted from fresh‑frozen laryngeal tumor and adjacent normal tissues, and was subjected to reverse transcription‑quantitative PCR for target detection. Statistical analyses were conducted using SPSS software, with significance set at P<0.05. The present study is the first, to the best of our knowledge, to report a positive moderate monotonic correlation (rs=0.347) and moderately strong positive linear correlation (r=0.630) between HIF3α mRNA and lncRNA MALAT1 in LSCC. Regression analysis revealed a direct association between 39.6% of both variables. Additionally, a positive correlation was observed between lncRNAs MALAT1 and HOTAIR (rs=0.353); HIF2α mRNA and lncRNA MALAT1 (rs=0.431); HIF3α mRNA and lncRNA HOTAIR (rs=0.279); and HIF3α mRNA and HIF2α mRNA (rs=0.285). Notably, a significant negative correlation (rs=‑0.341) was detected between HIF3α mRNA and HIF1α mRNA, potentially indicative of the HIF switch or negative regulation. In addition, the present study investigated the association between HIFα subunits and the clinicopathological characteristics of patients. The results revealed a notable association between HIF1α transcript levels and the location of LSCC; specifically, subglottic tumors exhibited elevated HIF1α levels compared with glottic and supraglottic LSCC. Furthermore, a significant association was identified between HIF3α transcript levels and patient age (P=0.032) and positive family history (P=0.047). In conclusion, the present findings suggested a pivotal role for HIF3α in LSCC development, potentially involving direct regulation of lncRNA MALAT1. However, further research is warranted to elucidate its precise mechanisms.

View Figures

View References

1	Sung H, Ferlay J, Siegel RL, Laversanne M, Soerjomataram I, Jemal A and Bray F: Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin. 71:209–249. 2021. View Article : Google Scholar : PubMed/NCBI
2	Nocini R, Molteni G, Mattiuzzi C and Lippi G: Updates on larynx cancer epidemiology. Chin J Cancer Res. 32:18–25. 2020. View Article : Google Scholar : PubMed/NCBI
3	Liberale C, Soloperto D, Marchioni A, Monzani D and Sacchetto L: Updates on larynx cancer: Risk factors and oncogenesis. Int J Mol Sci. 24:129132023. View Article : Google Scholar : PubMed/NCBI
4	Li MM, Zhao S, Eskander A, Rygalski C, Brock G, Parikh AS, Haring CT, Swendseid B, Zhan KY, Bradford CR, et al: Stage migration and survival trends in laryngeal cancer. Ann Surg Oncol. 28:7300–7309. 2021. View Article : Google Scholar : PubMed/NCBI
5	Satija S, Kaur H, Tambuwala MM, Sharma P, Vyas M, Khurana N, Sharma N, Bakshi HA, Charbe NB, Zacconi FC, et al: Hypoxia-Inducible Factor (HIF): Fuel for cancer progression. Curr Mol Pharmacol. 14:321–332. 2021. View Article : Google Scholar : PubMed/NCBI
6	Sebestyén A, Kopper L, Dankó T and Tímár J: Hypoxia signaling in cancer: From basics to clinical practice. Pathol Oncol Res. 27:16098022021. View Article : Google Scholar : PubMed/NCBI
7	Jaskiewicz M, Moszynska A, Serocki M, Króliczewski J, Bartoszewska S, Collawn JF and Bartoszewski R: Hypoxia-inducible factor (HIF)-3a2 serves as an endothelial cell fate executor during chronic hypoxia. EXCLI J. 21:454–469. 2022.PubMed/NCBI
8	Serocki M, Bartoszewska S, Janaszak-Jasiecka A, Ochocka RJ, Collawn JF and Bartoszewski R: miRNAs regulate the HIF switch during hypoxia: A novel therapeutic target. Angiogenesis. 21:183–202. 2018. View Article : Google Scholar : PubMed/NCBI
9	Janaszak-Jasiecka A, Bartoszewska S, Kochan K, Piotrowski A, Kalinowski L, Kamysz W, Ochocka RJ, Bartoszewski R and Collawn JF: miR-429 regulates the transition between hypoxiainducible factor (HIF)1A and HIF3A expression in human endothelial cells. Sci Rep. 6:227752016. View Article : Google Scholar : PubMed/NCBI
10	Duan C: Hypoxia-inducible factor 3 biology: complexities and emerging themes. Am J Physiol Cell Physiol. 310:C260–C269. 2016. View Article : Google Scholar : PubMed/NCBI
11	Tanimato K: Genetics of the hypoxia-inducible factors in human cancers. Exp Cell Res. 356:166–172. 2017. View Article : Google Scholar : PubMed/NCBI
12	St Laurent G, Wahlestedt C and Kapranov P: The Landscape of long noncoding RNA classification. Trends Genet. 31:239–251. 2015. View Article : Google Scholar : PubMed/NCBI
13	Zhou C, Ye L, Jiang C, Bai J, Chi Y and Zhang H: Long noncoding RNA HOTAIR, a hypoxia-inducible factor-1α activated driver of malignancy, enhances hypoxic cancer cell proliferation, migration, and invasion in non-small cell lung cancer. Tumour Biol. 36:9179–9188. 2015. View Article : Google Scholar : PubMed/NCBI
14	Li N, Meng DD, Gao L, Xu Y, Liu PJ, Tian YW, Yi ZY, Zhang Y, Tie XJ and Xu ZQ: Overexpression of HOTAIR leads to radioresistance of human cervical cancer via promoting HIF-1α expression. Radiat Oncol. 13:2102018. View Article : Google Scholar : PubMed/NCBI
15	Kabakov AE and Yakimova AO: Hypoxia-Induced cancer cell responses driving radioresistance of hypoxic tumors: Approaches to targeting and radiosensitizing. Cancers (Basel). 13:11022021. View Article : Google Scholar : PubMed/NCBI
16	Shih CH, Chuang LL, Tsai MH, Chen LH, Chuang EY, Lu TP and Lai LC: Hypoxia-Induced MALAT1 promotes the proliferation and migration of breast cancer cells by sponging MiR-3064-5p. Front Oncol. 11:6581512021. View Article : Google Scholar : PubMed/NCBI
17	Garo Kyurkchiyan S, Miroslavov Popov T, Stancheva G, Rangachev J, Ivanov Mitev V, Petrova Popova D and Petrova Kaneva R: Novel insights into laryngeal squamous cell carcinoma from association study of aberrantly expressed miRNAs, lncRNAs and clinical features in Bulgarian patients. J BUON. 25:357–366. 2020.PubMed/NCBI
18	Popov TM, Goranova T, Stancheva G, Kaneva R, Dikov T, Chalakov I, Rangachev J, Konov D, Todorov S, Stoyanov O and Mitev V: Relative quantitative expression of hypoxia-inducible factor-1α, −2α and −3α, and vascular endothelial growth factor A in laryngeal carcinoma. Oncol Lett. 9:2879–2885. 2015. View Article : Google Scholar : PubMed/NCBI
19	Livak KJ and Schmittgen TD: Analysis of relative gene expression data using real-time quantitative PCR and the 2(−Delta Delta C(T)) Method. Methods. 25:402–408. 2001. View Article : Google Scholar : PubMed/NCBI
20	Aiello A, Bacci L, Re A, Ripoli C, Pierconti F, Pinto F, Masetti R, Grassi C, Gaetano C, Bassi PF, et al: MALAT1 and HOTAIR Long Non-Coding RNAs play opposite role in estrogen-mediated transcriptional regulation in prostate cancer cells. Sci Rep. 6:384142016. View Article : Google Scholar : PubMed/NCBI
21	Xiao H, Zhu Q and Zhou J: Long non-coding RNA MALAT1 interaction with miR-429 regulates the proliferation and EMT of lung adenocarcinoma cells through RhoA. Int J Clin Exp Pathol. 12:419–430. 2019.PubMed/NCBI
22	Liu X, Zhao W and Wang X: Inhibition of long non-coding RNA MALAT1 elevates microRNA-429 to suppress the progression of hypopharyngeal squamous cell carcinoma by reducing ZEB1. Life Sci. 262:1184802020. View Article : Google Scholar : PubMed/NCBI
23	Fang H, Li HF, He MH, Yan JY, Yang M, Zhang FX, Wang RR, Wang QY and Zhang JP: Long non-coding RNA MALAT1 sponges microRNA-429 to regulate apoptosis of hippocampal neurons in hypoxic-ischemic brain damage by regulating WNT1. Brain Res Bull. 152:1–10. 2019. View Article : Google Scholar : PubMed/NCBI
24	Dzhalilova DS and Makarova OV: The role of hypoxia-inducible factor in the mechanisms of aging. Biochemistry (Mosc). 87:995–1014. 2022. View Article : Google Scholar : PubMed/NCBI
25	Ebersole JL, Novak MJ, Orraca L, Martinez-Gonzalez J, Kirakodu S, Chen KC, Stromberg A and Gonzalez OA: Hypoxia-inducible transcription factors, HIF1A and HIF2A, increase in aging mucosal tissues. Immunology. 154:452–464. 2018. View Article : Google Scholar : PubMed/NCBI
26	Shanbhogue KP, Prasad AS, Ucisik-Keser FE, Katabathina VS and Morani AC: Hereditary ovarian tumour syndromes: Current update on genetics and imaging. Clin Radiol. 76:313.e15–313.e26. 2021. View Article : Google Scholar : PubMed/NCBI
27	Wu XH, Chen SP, Mao JY, Ji XX, Yao HT and Zhou SH: Expression and significance of hypoxia-inducible factor-1α and glucose transporter-1 in laryngeal carcinoma. Oncol Lett. 5:261–266. 2013. View Article : Google Scholar : PubMed/NCBI
28	Singh P, Rajput M and Pandey M: Tumor hypoxia and role of hypoxia-inducible factor in oral cancer. World J Surg Oncol. 22:182024. View Article : Google Scholar : PubMed/NCBI
29	Bronikowska I, Swietochowska E, Morawski R, Sowa P and Czecior E: Concentration of hypoxia-inducible factor-1, glucose transporter 1 and vascular endothelial growth factor in tissue samples and serum in patients with primary laryngeal carcinoma. Acta Otolaryngol. 142:532–536. 2022. View Article : Google Scholar : PubMed/NCBI
30	Forristal CE, Wright KL, Hanley NA, Oreffo RO and Houghton FD: Hypoxia inducible factors regulate pluripotency and proliferation in human embryonic stem cells cultured at reduced oxygen tensions. Reproduction. 139:85–97. 2010. View Article : Google Scholar : PubMed/NCBI
31	Xu Z, Lv H, Wang Y, Hu C, Chen S, Du Y, Shi C and Cheng X: HAND2-AS1 inhibits gastric adenocarcinoma cells proliferation and aerobic glycolysis via miRNAs Sponge. Cancer Manag Res. 12:3053–3068. 2020. View Article : Google Scholar : PubMed/NCBI
32	Liu P, Fang X, Song Y, Jiang JX, He QJ and Liu XJ: Expression of hypoxia-inducible factor 3α in hepatocellular carcinoma and its association with other hypoxia-inducible factors. Exp Ther Med. 11:2470–2476. 2016. View Article : Google Scholar : PubMed/NCBI
33	Kirschner KM, Kelterborn S, Stehr H, Penzlin JLT, Jacobi CLJ, Endesfelder S, Sieg M, Kruppa J, Dame C and Sciesielski LK: Adaptation of the oxygen sensing system during lung development. Oxid Med Cell Longev. 2022:97146692022. View Article : Google Scholar : PubMed/NCBI